Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. (Q44781560)
Jump to navigation
Jump to search
scientific article published on 21 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. |
scientific article published on 21 May 2013 |
Statements
1 reference
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077. (English)
1 reference
Dietger Niederwieser
1 reference
Wolfram Pönisch
1 reference
Simone Heyn
1 reference
Juliane Beck
1 reference
Ina Wagner
1 reference
Martin Mohren
1 reference
Franz A Hoffmann
1 reference
Thoralf Lange
1 reference
Marion Schmalfeld
1 reference
Thomas Zehrfeld
1 reference
Andreas Schwarzer
1 reference
Cornelia Winkelmann
1 reference
Thomas Edelmann
1 reference
Ramona Röhrborn
1 reference
Karin Hebenstreit
1 reference
Haifa K Al-Ali
1 reference
Nadja Jäkel
1 reference
21 May 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference